Save time and get answers to complex questions with AI chat
What's the recommended schedule for lurbinectedin side effect checks?Dabrafenib mesylate when the patent is expiring in india?Can wine consumption affect lipitor's cholesterol lowering ability?Prolia and osteonecrosis?When does guselkumab patent expire?
See the DrugPatentWatch profile for Trelegy
Trelegy is a brand name for a triple-therapy inhaler used for COPD (and sometimes other obstructive lung diseases). In Canada, “Trelegy” typically refers to one of the following strengths/devices: - TRELEGY ELLIPTA 100/62.5/25 mcg (often indicated for COPD) - TRELEGY ELLIPTA 200/62.5/25 mcg (a higher steroid dose) - It may also be supplied in other country-specific formats/strengths depending on availability. What’s inside (the “triple” part): - Fluticasone furoate (an inhaled corticosteroid) - Umeclidinium (a LAMA: long-acting muscarinic antagonist) - Vilanterol (a LABA: long-acting beta2-agonist) Common uses - Maintenance treatment of COPD to reduce exacerbations and improve symptoms. Common side effects - Throat irritation/hoarseness (from the steroid) - Dry mouth - Cough - Headache - Possible increased risk of oral thrush (rinse/gargle after use) Important notes - It’s not a rescue inhaler for sudden breathing attacks. - Rinse your mouth after each dose to reduce steroid-related mouth issues. - If you tell me your dose/strength on the box (or the exact name), I can be more specific about dosing and how it’s taken. What would you like to know about “Trelegy Canada”? 1) The exact strength/form available? 2) How to use the Ellipta inhaler? 3) Side effects / interactions? 4) Whether it’s appropriate for COPD vs asthma?
Other Questions About Trelegy :